PATENT CLAIM ANALYSIS

Application Number: 15749100
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "264110"]

Abstract:
The present invention relates to an adduct of palbociclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.

Claim (Index 8):
Palbociclib in crystalline form having characteristic X-ray powder diffraction peak(s) at 6.0, 10.9, 12.8, 16.3 and 19.7 degrees 2\u03b8 (\u00b10.2 degrees 2\u03b8).

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15115063', '16331915', '15565807', '15539147', '15753993']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7325844696036263
- 35 USC 102 Novelty (BERT): 0.497794083595202
- Combined Prediction Score: 0.7091054310027839
- Mean Citation Score: 207.953016
- Max Citation Score: 220.68631
- Similarity Product: 165.97088445382713

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test